Global Immuno-Oncology Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Immuno-Oncology Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Immuno-Oncology Treatment industry chain, the market status of Hospitals (Immune Checkpoint Inhibitors, Monoclonal Antibodies), Ambulatory Surgical Center (Immune Checkpoint Inhibitors, Monoclonal Antibodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immuno-Oncology Treatment.
Regionally, the report analyzes the Immuno-Oncology Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immuno-Oncology Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immuno-Oncology Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immuno-Oncology Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immune Checkpoint Inhibitors, Monoclonal Antibodies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immuno-Oncology Treatment market.
Regional Analysis: The report involves examining the Immuno-Oncology Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immuno-Oncology Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immuno-Oncology Treatment:
Company Analysis: Report covers individual Immuno-Oncology Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immuno-Oncology Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Center).
Technology Analysis: Report covers specific technologies relevant to Immuno-Oncology Treatment. It assesses the current state, advancements, and potential future developments in Immuno-Oncology Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immuno-Oncology Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immuno-Oncology Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Immuno-Oncology Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology Treatment, with revenue, gross margin and global market share of Immuno-Oncology Treatment from 2019 to 2024.
Chapter 3, the Immuno-Oncology Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-Oncology Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology Treatment.
Chapter 13, to describe Immuno-Oncology Treatment research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Immuno-Oncology Treatment industry chain, the market status of Hospitals (Immune Checkpoint Inhibitors, Monoclonal Antibodies), Ambulatory Surgical Center (Immune Checkpoint Inhibitors, Monoclonal Antibodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immuno-Oncology Treatment.
Regionally, the report analyzes the Immuno-Oncology Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immuno-Oncology Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immuno-Oncology Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immuno-Oncology Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immune Checkpoint Inhibitors, Monoclonal Antibodies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immuno-Oncology Treatment market.
Regional Analysis: The report involves examining the Immuno-Oncology Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immuno-Oncology Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immuno-Oncology Treatment:
Company Analysis: Report covers individual Immuno-Oncology Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immuno-Oncology Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Center).
Technology Analysis: Report covers specific technologies relevant to Immuno-Oncology Treatment. It assesses the current state, advancements, and potential future developments in Immuno-Oncology Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immuno-Oncology Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immuno-Oncology Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Immune Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Hospitals
- Ambulatory Surgical Center
- Others
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli-Lilly
- Roche
- GlaxoSmithKline
- Janssen Biotech
- Merck
- Novartis
- Pfizer
- Sanofi
- Spectrum Pharmaceuticals
- Takeda
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Immuno-Oncology Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology Treatment, with revenue, gross margin and global market share of Immuno-Oncology Treatment from 2019 to 2024.
Chapter 3, the Immuno-Oncology Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-Oncology Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology Treatment.
Chapter 13, to describe Immuno-Oncology Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immuno-Oncology Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-Oncology Treatment by Type
1.3.1 Overview: Global Immuno-Oncology Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Immuno-Oncology Treatment Consumption Value Market Share by Type in 2023
1.3.3 Immune Checkpoint Inhibitors
1.3.4 Monoclonal Antibodies
1.3.5 Cytokine-Based Immunotherapy
1.3.6 Cancer Vaccines
1.3.7 CAR-T Cell Therapy
1.4 Global Immuno-Oncology Treatment Market by Application
1.4.1 Overview: Global Immuno-Oncology Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Center
1.4.4 Others
1.5 Global Immuno-Oncology Treatment Market Size & Forecast
1.6 Global Immuno-Oncology Treatment Market Size and Forecast by Region
1.6.1 Global Immuno-Oncology Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immuno-Oncology Treatment Market Size by Region, (2019-2030)
1.6.3 North America Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.6 South America Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Immuno-Oncology Treatment Product and Solutions
2.1.4 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Immuno-Oncology Treatment Product and Solutions
2.2.4 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
2.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Eli-Lilly
2.4.1 Eli-Lilly Details
2.4.2 Eli-Lilly Major Business
2.4.3 Eli-Lilly Immuno-Oncology Treatment Product and Solutions
2.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli-Lilly Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Immuno-Oncology Treatment Product and Solutions
2.5.4 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
2.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Janssen Biotech
2.7.1 Janssen Biotech Details
2.7.2 Janssen Biotech Major Business
2.7.3 Janssen Biotech Immuno-Oncology Treatment Product and Solutions
2.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Janssen Biotech Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Immuno-Oncology Treatment Product and Solutions
2.8.4 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Immuno-Oncology Treatment Product and Solutions
2.9.4 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Immuno-Oncology Treatment Product and Solutions
2.10.4 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Immuno-Oncology Treatment Product and Solutions
2.11.4 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business
2.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
2.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Immuno-Oncology Treatment Product and Solutions
2.13.4 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immuno-Oncology Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Immuno-Oncology Treatment by Company Revenue
3.2.2 Top 3 Immuno-Oncology Treatment Players Market Share in 2023
3.2.3 Top 6 Immuno-Oncology Treatment Players Market Share in 2023
3.3 Immuno-Oncology Treatment Market: Overall Company Footprint Analysis
3.3.1 Immuno-Oncology Treatment Market: Region Footprint
3.3.2 Immuno-Oncology Treatment Market: Company Product Type Footprint
3.3.3 Immuno-Oncology Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immuno-Oncology Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global Immuno-Oncology Treatment Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2024)
5.2 Global Immuno-Oncology Treatment Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
6.2 North America Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
6.3 North America Immuno-Oncology Treatment Market Size by Country
6.3.1 North America Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
6.3.2 United States Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
7.2 Europe Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
7.3 Europe Immuno-Oncology Treatment Market Size by Country
7.3.1 Europe Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.3 France Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
8.3.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2019-2030)
8.3.2 China Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.5 India Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
9.2 South America Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
9.3 South America Immuno-Oncology Treatment Market Size by Country
9.3.1 South America Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
10.3.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Immuno-Oncology Treatment Market Drivers
11.2 Immuno-Oncology Treatment Market Restraints
11.3 Immuno-Oncology Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Immuno-Oncology Treatment Industry Chain
12.2 Immuno-Oncology Treatment Upstream Analysis
12.3 Immuno-Oncology Treatment Midstream Analysis
12.4 Immuno-Oncology Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Immuno-Oncology Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-Oncology Treatment by Type
1.3.1 Overview: Global Immuno-Oncology Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Immuno-Oncology Treatment Consumption Value Market Share by Type in 2023
1.3.3 Immune Checkpoint Inhibitors
1.3.4 Monoclonal Antibodies
1.3.5 Cytokine-Based Immunotherapy
1.3.6 Cancer Vaccines
1.3.7 CAR-T Cell Therapy
1.4 Global Immuno-Oncology Treatment Market by Application
1.4.1 Overview: Global Immuno-Oncology Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Center
1.4.4 Others
1.5 Global Immuno-Oncology Treatment Market Size & Forecast
1.6 Global Immuno-Oncology Treatment Market Size and Forecast by Region
1.6.1 Global Immuno-Oncology Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immuno-Oncology Treatment Market Size by Region, (2019-2030)
1.6.3 North America Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.6 South America Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Immuno-Oncology Treatment Product and Solutions
2.1.4 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Immuno-Oncology Treatment Product and Solutions
2.2.4 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
2.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 Eli-Lilly
2.4.1 Eli-Lilly Details
2.4.2 Eli-Lilly Major Business
2.4.3 Eli-Lilly Immuno-Oncology Treatment Product and Solutions
2.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli-Lilly Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Immuno-Oncology Treatment Product and Solutions
2.5.4 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
2.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments and Future Plans
2.7 Janssen Biotech
2.7.1 Janssen Biotech Details
2.7.2 Janssen Biotech Major Business
2.7.3 Janssen Biotech Immuno-Oncology Treatment Product and Solutions
2.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Janssen Biotech Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Immuno-Oncology Treatment Product and Solutions
2.8.4 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Immuno-Oncology Treatment Product and Solutions
2.9.4 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Immuno-Oncology Treatment Product and Solutions
2.10.4 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Immuno-Oncology Treatment Product and Solutions
2.11.4 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Spectrum Pharmaceuticals
2.12.1 Spectrum Pharmaceuticals Details
2.12.2 Spectrum Pharmaceuticals Major Business
2.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
2.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Immuno-Oncology Treatment Product and Solutions
2.13.4 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immuno-Oncology Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Immuno-Oncology Treatment by Company Revenue
3.2.2 Top 3 Immuno-Oncology Treatment Players Market Share in 2023
3.2.3 Top 6 Immuno-Oncology Treatment Players Market Share in 2023
3.3 Immuno-Oncology Treatment Market: Overall Company Footprint Analysis
3.3.1 Immuno-Oncology Treatment Market: Region Footprint
3.3.2 Immuno-Oncology Treatment Market: Company Product Type Footprint
3.3.3 Immuno-Oncology Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immuno-Oncology Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global Immuno-Oncology Treatment Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2024)
5.2 Global Immuno-Oncology Treatment Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
6.2 North America Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
6.3 North America Immuno-Oncology Treatment Market Size by Country
6.3.1 North America Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
6.3.2 United States Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
7.2 Europe Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
7.3 Europe Immuno-Oncology Treatment Market Size by Country
7.3.1 Europe Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.3 France Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
8.3.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2019-2030)
8.3.2 China Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.5 India Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
9.2 South America Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
9.3 South America Immuno-Oncology Treatment Market Size by Country
9.3.1 South America Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
10.3.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Immuno-Oncology Treatment Market Drivers
11.2 Immuno-Oncology Treatment Market Restraints
11.3 Immuno-Oncology Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Immuno-Oncology Treatment Industry Chain
12.2 Immuno-Oncology Treatment Upstream Analysis
12.3 Immuno-Oncology Treatment Midstream Analysis
12.4 Immuno-Oncology Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
